Warning on risks: Financial contracts for difference are complex instruments and are associated with a high risk of rapid financial losses due to leverage. On 81.54% of retail investor accounts, financial losses occur when trading financial contracts for difference with this provider. You should consider whether you understand how financial contracts for difference work, and whether you can afford to take the high risk of suffering financial losses. Please read the Risk Disclosures.

Logo icon

Market analysis and news

Get an overview of current market developments with regular analysis from our analysts. We offer a detailed view of key events, economic indicators and investment opportunities. Follow the development of the markets with us and make decisions based on data and experience.

Group 3122
Group 3373
Study

How We Went From Savers to Investors

35 Years Since the Beginning of Voucher Privatization in Czechoslovakia
Emily Bernal V9vII5gV8Lw Unsplash
22/12/2023
Adobe grows despite botched $20 billion merger
Adobe's ambitious plan to acquire Figma for $20 billion, a move that was supposed to reshape the creative software landscape, fell through. It has been stalled by significant regulatory hurdles. The failed acquisition, announced back in September 2022, represented Adobe's strategy to expand its online creative offerings and take advantage of Figma's fast-growing market.
Pawel Czerwinski Px7rw3I3e1M Unsplash
17/12/2023
Coca Cola dominates the market and reminds us of Christmas
Coca-Cola products have become a staple in homes all year round. But at Christmas, Coke products are particularly visible thanks to a clever advertising campaign that links the figure of Santa to the iconic brand. Yet incredibly, some 33 billion packs of the brand's products were sold in more than 200 countries last year.
Mufid Majnun GFHYAWyXCbw Unsplash
10/12/2023
AstraZeneca joins the race for weight loss drug
More than one billion people worldwide are overweight or obese. AstraZeneca (AZN.L) has bet on the booming market for obesity drugs by announcing a $2 billion investment to license an experimental drug from Chinese company Eccogene.
Christina Telep IS6CslWJrjY Unsplash
28/11/2023
Toyota sells companies to make more EVs
Toyota group companies plan to sell stake in Denso worth $4.7 billion. As a result, Toyota Motors and its two affiliates plan to sell about 10 percent of component maker Denso by the end of the year, reducing Toyota's stake in Denso from 24.2 percent and Denso, which will remain the major shareholder. 

Latest analyses